Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Aug 14, 2025

SELL
$0.0 - $228.9 $0 - $11,445
-50 Closed
0 $0
Q4 2020

Aug 14, 2025

BUY
$164.63 - $211.93 $8,231 - $10,596
50 New
50 $8.76 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Towarzystwo Funduszy Inwestycyjnych Pzu Sa Portfolio

Follow Towarzystwo Funduszy Inwestycyjnych Pzu Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Towarzystwo Funduszy Inwestycyjnych Pzu Sa, based on Form 13F filings with the SEC.

News

Stay updated on Towarzystwo Funduszy Inwestycyjnych Pzu Sa with notifications on news.